Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
09/11/1998 | WO1998039015A1 Opthalmic composition |
09/11/1998 | WO1998038987A1 Pharmaceutical formulations containing poorly soluble drug substances |
09/11/1998 | WO1998038984A2 Formulations for hydrophobic pharmaceutical agents |
09/11/1998 | WO1998038983A2 Swallow tablet comprising paracetamol |
09/11/1998 | WO1998031712A3 Chitosan-conjugates with acidic chelate-complex forming agents |
09/11/1998 | WO1998031393A3 Polysaccharide-peptide-conjugates |
09/11/1998 | WO1998030245A3 Injection implant |
09/11/1998 | WO1998030190A3 Colon cancer KH-1 and N3 antigens |
09/11/1998 | WO1998029535A3 Nanoscale particles synthesized within an assembled virion |
09/11/1998 | WO1998027961A3 Antitussive drugs delivered by partially coated ion exchange resins |
09/11/1998 | WO1998027960A3 A nitroimidazole gel composition |
09/11/1998 | WO1998023262A3 Lozenge for the modified releasing of active substances in the gastrointestinal tract |
09/11/1998 | WO1998020135A3 Protease-activatable pseudomonas exotoxin a-like proproteins |
09/11/1998 | CA2614782A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
09/11/1998 | CA2282708A1 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof |
09/10/1998 | DE19708668A1 Use of tocopheryl acetate in saline applied to oral mucosa as bronchodilator to treat e.g. bronchitis, bronchial asthma and mucoviscidosis |
09/10/1998 | CA2228818A1 The use of redispersible polymer powders or polymer granules for coating pharmaceutical or agrochemical use forms |
09/09/1998 | EP0863139A1 Benzoxazindione derivatives, process for their preparation and their use |
09/09/1998 | EP0862915A1 Antibacterial composition for oral administration |
09/09/1998 | EP0862463A1 Solid mixtures of cyclodextrins prepared via melt-extrusion |
09/09/1998 | EP0862456A1 Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
09/09/1998 | EP0862453A1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
09/09/1998 | EP0862452A1 Stabilizing formulation for ngf |
09/09/1998 | EP0862441A1 Vaginal pharmaceutical compositions containing a peroxide source |
09/09/1998 | EP0862439A1 Ligands to enhance cellular uptake of biomolecules |
09/09/1998 | EP0862437A1 Pharmaceutical formulations |
09/09/1998 | EP0862434A1 Infusions of neuroprotectants and perfluorochemicals |
09/09/1998 | EP0862422A1 Cellulose acetate phthalate enteric coating compositions |
09/09/1998 | EP0862416A1 Non-polymeric sustained release delivery system |
09/09/1998 | EP0862414A1 Ophthalmic compositions containing cyclodextrins and quaternary ammonium compounds |
09/09/1998 | EP0813425A4 Metal radionuclide labeled proteins for diagnosis and therapy |
09/09/1998 | EP0799028B1 A controlled release formulation for poorly soluble basic drugs |
09/09/1998 | EP0651641B1 Novel bioactive compositions, preparation and use thereof |
09/09/1998 | EP0512050B1 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
09/09/1998 | EP0478732B1 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
09/09/1998 | CN1192759A Block polymer having functional groups at both ends |
09/09/1998 | CN1192691A Stable freeze-dried composition contg. TPO |
09/09/1998 | CN1192690A Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
09/09/1998 | CN1192684A Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
09/09/1998 | CN1192678A Biological agent compositions |
09/09/1998 | CN1192654A Novel embolizing compositions |
09/09/1998 | CN1192333A Use of solubilized carotenoid prepn. for colouring foods and pharmaceutical prepns. |
09/09/1998 | CN1039672C Quick-drying gel-type disinfectant for hands and fingers |
09/08/1998 | USRE35893 Dry, uniform, free-flowing granular combination of water soluble carbohydrate-based agglomerate and liquid nonaqueous antifoaming or defoaming composition of hydrocarbon, mineral or silicone oil containing silica |
09/08/1998 | US5804604 Agent for intracellular delivery of cargo moiety |
09/08/1998 | US5804573 With additive antioxidant, polyoxyalkyl stabilizer, carrier |
09/08/1998 | US5804568 Pharmaceutical formulation |
09/08/1998 | US5804561 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
09/08/1998 | US5804557 Excipient stabilization of polypeptides treated with organic solvents |
09/08/1998 | US5804217 Abhesively shearing a cellulose or derivative raw material during controlled and gradual addition of aqueous mixing fluid to form particle spheres, drying |
09/08/1998 | US5804212 Administering bioadhesive microspheres and an active drug |
09/08/1998 | US5804209 Bioadhesive starches and process for their preparation |
09/08/1998 | US5804203 Topical product formulations containing strontium for reducing skin irritation |
09/08/1998 | US5804202 Mixing topical adjuvant with water in oil emulsion containing acrylamide, 2-acrylamido-2-methylpropanesulfonic acid, and allyl sucrose, allyl pentaerythritol, or methylene-bisacrylamide; skin, hair care products |
09/08/1998 | US5804196 Self assembled, defective, nonself-propagating viral particles |
09/08/1998 | US5804183 Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same |
09/08/1998 | US5804177 Method of using CD24 as a cell marker |
09/05/1998 | CA2230965A1 New benzoxazinedione derivatives, a method of producing them and the use thereof |
09/03/1998 | WO1998038513A1 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
09/03/1998 | WO1998038327A1 Marine bacterial strain of the genus vibrio, water-soluble polysaccharides produced by said strain and their uses |
09/03/1998 | WO1998037916A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use |
09/03/1998 | WO1998037915A1 Antibiotic-ligand conjugates and methods of use thereof |
09/03/1998 | WO1998037884A1 Inclusion complexes in aqueous solution |
09/03/1998 | WO1998037879A1 Nimesulide gel systems for topical use |
09/03/1998 | WO1998037876A1 Pharmaceutical composition for the programmed release of dexfenfluramine |
09/03/1998 | WO1998037875A1 Drug composition |
09/03/1998 | WO1998037871A1 Transdermal device for the delivery of testosterone |
09/03/1998 | WO1998037870A1 Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
09/03/1998 | WO1998037867A1 Mixtures of alkylphosphoric acid esters and their use as cosmetic and pharmaceutical emulsifiers |
09/03/1998 | DE19707800A1 Mischungen von Alkylphosphorsäureestern und deren Verwendung als kosmetische und pharmazeutische Emulgatoren Mixtures of alkylphosphoric esters and their use as cosmetic and pharmaceutical emulsifiers |
09/03/1998 | CA2281876A1 Transdermal device for the delivery of testosterone |
09/03/1998 | CA2280980A1 Pharmaceutical composition for the programmed release of dexfenfluramine |
09/03/1998 | CA2279277A1 Nimesulide gel systems for topical use |
09/03/1998 | CA2252942A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use |
09/02/1998 | EP0861848A1 Glycolipid derivatives and use thereof |
09/02/1998 | EP0861667A2 Particulate agents |
09/02/1998 | EP0861659A1 Sustained release drug delivery devices |
09/02/1998 | EP0861658A1 Preservative for emulsion and emulsion containing same |
09/02/1998 | EP0861657A2 Monohydric alcohol-free composition for topical use comprising solubilized ethylcellulose |
09/02/1998 | EP0861270A1 Photocured cross-linked-hyaluronic acid gel and method of preparation thereof |
09/02/1998 | EP0861228A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
09/02/1998 | EP0861091A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
09/02/1998 | EP0861090A1 Tumor associated internalizing antigens and methods for targeting therapeutic agents |
09/02/1998 | EP0861084A1 Improved process and composition for therapeutic cisplatin (cddp) |
09/02/1998 | EP0861082A1 Therapy for tissue membrane insufficiency |
09/02/1998 | EP0861073A1 Stabilized thyroid hormone preparations and methods of making same |
09/02/1998 | EP0861067A1 Unit galenical form for local hormonotherapy of vaginal dryness |
09/02/1998 | EP0525177B1 Unimolecular micelles and method of making the same |
09/02/1998 | EP0482213B1 Antineoplastic agent |
09/02/1998 | CN1192240A Recombinant mistletoe lectin (rML) |
09/02/1998 | CN1192152A Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
09/02/1998 | CN1192136A Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir |
09/02/1998 | CN1192134A Topical vehicles containing solubilized and stabilized azelaic acid |
09/02/1998 | CN1192131A High viscosity liquid controlled delivery system |
09/02/1998 | CN1191723A Compound eye drops for preventing and treating eye infection and its preparation |
09/01/1998 | US5801229 Radiation sensitizers; antitumor agents |
09/01/1998 | US5801226 Oral care compositions |
09/01/1998 | US5801191 Taxoids |
09/01/1998 | US5801033 Gels for encapsulation of biological materials |
09/01/1998 | US5801019 DNA encoding fused alpha-beta globin pseuodimer and production of pseudotetrameric hemoglobin |